FDA
FDA OKs Herpes Blood Test
FDA OKs Herpes Blood Test
Kerry Grens | Jul 6, 2015
The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.
Anti-Vax Doctor Found Dead
Anti-Vax Doctor Found Dead
Bob Grant | Jun 30, 2015
Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.
Device Trials Go Unpublished
Device Trials Go Unpublished
Kerry Grens | Jun 24, 2015
Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.
Edible Marijuana Labels Wrong
Edible Marijuana Labels Wrong
Bob Grant | Jun 24, 2015
The dosage information on 83 percent of 75 edible marijuana products legally sold in Seattle, San Francisco, and Los Angeles was incorrect.
Drug for Low Sex Drive in Women?
Drug for Low Sex Drive in Women?
Jef Akst | Jun 8, 2015
A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.
NIH Halts Drug Production
NIH Halts Drug Production
Tracy Vence | Jun 8, 2015
The National Institutes of Health’s Pharmaceutical Development Section temporarily suspends production following contamination issues.
FDA Calls for Data on ALS Drug
FDA Calls for Data on ALS Drug
Jef Akst | Apr 21, 2015
In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.
ALS Drug Access Debated
ALS Drug Access Debated
Jef Akst | Apr 7, 2015
Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.
FDA Deems GM Apples, Potatoes Safe
FDA Deems GM Apples, Potatoes Safe
Tracy Vence | Mar 23, 2015
Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.
FDA OKs First Biosimilar
FDA OKs First Biosimilar
Tracy Vence | Mar 6, 2015
The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.